ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 228 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2023. The put-call ratio across all filers is 5.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $7,837 | +22.9% | 747,109 | +54.0% | 0.05% | -16.4% |
Q3 2023 | $6,376 | +49.3% | 485,202 | +43.1% | 0.06% | +74.3% |
Q2 2023 | $4,272 | -34.4% | 339,064 | -32.0% | 0.04% | -35.2% |
Q1 2023 | $6,511 | +783.4% | 498,919 | +1094.3% | 0.05% | +390.9% |
Q4 2022 | $737 | -99.9% | 41,776 | -28.6% | 0.01% | -8.3% |
Q3 2022 | $891,000 | -22.3% | 58,484 | -24.3% | 0.01% | -14.3% |
Q2 2022 | $1,146,000 | -65.8% | 77,291 | -48.1% | 0.01% | -66.7% |
Q1 2022 | $3,353,000 | +111.8% | 148,873 | +73.5% | 0.04% | +162.5% |
Q4 2021 | $1,583,000 | -49.3% | 85,806 | -63.3% | 0.02% | -61.9% |
Q3 2021 | $3,123,000 | +101.4% | 233,563 | +126.1% | 0.04% | +82.6% |
Q1 2021 | $1,551,000 | -54.7% | 103,305 | -56.4% | 0.02% | -30.3% |
Q4 2020 | $3,423,000 | +613.1% | 236,858 | +301.8% | 0.03% | +230.0% |
Q3 2020 | $480,000 | +42.9% | 58,946 | +18.7% | 0.01% | +11.1% |
Q2 2020 | $336,000 | -53.8% | 49,654 | -33.0% | 0.01% | -35.7% |
Q4 2019 | $727,000 | – | 74,101 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |